North West State Medical University named after Mechnikov, St. Petersburg, Russian Federation.
Ural State Medical University, Yekaterinburg, Russian Federation.
Arch Osteoporos. 2021 Jun 5;16(1):87. doi: 10.1007/s11657-021-00962-1.
Age-specific intervention and assessment thresholds based on FRAX® were developed for eight Eurasian countries participating in the EVA study (Armenia, Belarus, Georgia, Moldova, Kazakhstan, the Kyrgyz Republic, the Russian Federation, and Uzbekistan). The intervention thresholds (major osteoporotic fracture) ranged from 3.6 (Armenia and Georgia) to 12.3% (Uzbekistan) for people at age 50 years, and from 16 (Armenia) to 27% (Belarus) at the age of 90 years. These thresholds enable a substantial advance in the ease of detection of individuals at high fracture risk.
The purpose of this study was to derive and compare FRAX-based intervention and BMD assessment thresholds for 8 Eurasian countries in the EVA study.
The intervention threshold (IT) was set at a 10-year probability of a major osteoporotic fracture (MOF), calculated without BMD, equivalent to a woman with a prior fragility fracture but no other clinical risk factors, and a body mass index (BMI) of 25.0 kg/m. The lower assessment threshold was set at a 10-year probability of a MOF in women with BMI of 25.0 kg/m, without previous fracture or other clinical risk factors. The upper assessment threshold was set at 1.2 times the IT.
The age-specific intervention thresholds ranged from 3.6 (Armenia and Georgia) to 12.3% (Uzbekistan) for men and women at the age of 50 years and from 16 (Armenia) to 27% (Belarus) at the age of 90 years. The difference between countries was most evident at younger ages and become progressively less with advancing age.
For the 8 Eurasian countries, the newly established FRAX-based intervention thresholds provide an opportunity to improve the clinical detection of both men and women with a high risk of fracture and improve treatment rates.
本研究旨在为 EVA 研究中的 8 个欧亚国家制定并比较基于 FRAX 的干预和 BMD 评估阈值。
干预阈值 (IT) 设定为无 BMD 计算的 10 年主要骨质疏松性骨折 (MOF) 概率,相当于有脆性骨折但无其他临床危险因素且 BMI 为 25.0 kg/m 的女性。较低的评估阈值设定为 BMI 为 25.0 kg/m 的无既往骨折或其他临床危险因素的女性 10 年 MOF 概率。较高的评估阈值设定为 IT 的 1.2 倍。
年龄特异性干预阈值在 50 岁的男性和女性中范围为 3.6(亚美尼亚和格鲁吉亚)至 12.3%(乌兹别克斯坦),在 90 岁时范围为 16(亚美尼亚)至 27%(白俄罗斯)。各国之间的差异在年轻时期最为明显,随着年龄的增长逐渐减少。
对于 8 个欧亚国家,新建立的基于 FRAX 的干预阈值为提高对高骨折风险的男性和女性的临床检测提供了机会,并提高了治疗率。